(Total Views: 504)
Posted On: 01/12/2020 10:27:55 AM
Post# of 154047
Did we confirm that the last two patients are #2 and #3 for the phase 2 trial and not emergency IND patients? I don’t recall NP differentiating between them, but I assumed their for the phase 2.
Like I’ve said before, my hope is that NP waits to file for BTD until there are a few CTC results from these two patients, at a minimum. He initially said 4-5 patients and my hope is that he sticks to that. The more data the better when working with the FDA and honestly, what’s the rush? BTD won’t speed up the current trial and more effort should be on filling up the trial as quickly as possible.
Like I’ve said before, my hope is that NP waits to file for BTD until there are a few CTC results from these two patients, at a minimum. He initially said 4-5 patients and my hope is that he sticks to that. The more data the better when working with the FDA and honestly, what’s the rush? BTD won’t speed up the current trial and more effort should be on filling up the trial as quickly as possible.
(0)
(0)
